Estrella Immunopharma, Inc. (ESLAW)
USD 0.05
(-45.12%)
USD 0.05
(-45.12%)
| Breakdown | 2024 | 2022 | 2022 | 2021 |
|---|---|---|---|---|
| Total Assets | 4.45 Million | 9.98 Million | 4.92 Million | - |
| Total Current Assets | 4.45 Million | 52.42 Thousand | 4.92 Million | - |
| Cash And Short Term Investments | 4.16 Million | 40.8 Thousand | 4.08 Million | - |
| Cash and Cash Equivalents | 4.16 Million | 40.8 Thousand | 4.08 Million | - |
| Short Term Investments | - | - | - | - |
| Net Receivables | 288.76 Thousand | - | - | - |
| Inventory | -288.76 Thousand | - | - | - |
| Other Current Assets | 288.76 Thousand | 11.62 Thousand | 137.16 Thousand | - |
| Total Non-Current Assets | - | 9.93 Million | 45.18 Million | - |
| Net PPE | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - |
| Good Will | - | - | - | - |
| Intangible Assets | - | - | - | - |
| Long-Term Investments | - | 9.67 Million | 45.18 Million | - |
| Tax Assets | - | 262.68 Thousand | - | - |
| Other Non Current Assets | - | - | - | - |
| Other Assets | - | - | -45.18 Million | - |
| Total Liabilities | 180.7 Thousand | 2.91 Million | 5.96 Million | - |
| Total Current Liabilities | 180.7 Thousand | 1.07 Million | 946.68 Thousand | - |
| Account Payables | - | - | 945.58 Thousand | - |
| Tax Payables | 44.87 Thousand | 51.17 Thousand | 1097.00 | - |
| Short Term Debt | - | 498.6 Thousand | - | - |
| Deferred Revenue | - | - | - | - |
| Other Current Liabilities | 180.7 Thousand | 574.46 Thousand | 1097.00 | - |
| Total Non Current Liabilities | - | 1.84 Million | 5.01 Million | - |
| Long-Term Debt | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - |
| Other Non Current Liabilities | - | 1.55 Million | 5.01 Million | - |
| Other Liabilities | - | 1.00 | - | - |
| Total Equity | 4.27 Million | 7.07 Million | -1.03 Million | - |
| Stock Holders Equity | 4.27 Million | 7.07 Million | -1.03 Million | - |
| Common Stock | 3661.00 | 9.32 Million | 18.00 | - |
| Retained Earnings | -19.5 Million | -2.25 Million | -1.07 Million | - |
| Accumulated other comprehensive income | -3661.00 | - | - | - |
| Common Stock Equity | 4.27 Million | 7.07 Million | -1.03 Million | - |
| Capital Lease Obligation | - | - | - | - |
| Total Investments | - | 9.67 Million | 45.18 Million | - |
| Total Debt | - | 498.6 Thousand | - | - |
| Net Debt | -4.16 Million | 457.79 Thousand | -4.08 Million | - |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Total Assets | 4.45 Million | 8.63 Million | 9.44 Million | 27.34 Million | 10.25 Million | 10.09 Million |
| Total Current Assets | 4.45 Million | 8.63 Million | 9.44 Million | 27.34 Million | 129.36 Thousand | 81.89 Thousand |
| Cash And Short Term Investments | 4.16 Million | 4.72 Million | 9.04 Million | 22.13 Million | 34.68 Thousand | 29.39 Thousand |
| Cash and Cash Equivalents | 4.16 Million | 4.72 Million | 9.04 Million | 22.13 Million | 34.68 Thousand | 29.39 Thousand |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | 288.76 Thousand | 406.11 Thousand | - | - | - | - |
| Inventory | -288.76 Thousand | -406.11 Thousand | - | - | - | - |
| Other Current Assets | 288.76 Thousand | 3.9 Million | 401.24 Thousand | 5.21 Million | 94.67 Thousand | 52.5 Thousand |
| Total Non-Current Assets | - | - | - | - | 10.12 Million | 10 Million |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | 9.79 Million | 9.69 Million |
| Tax Assets | - | - | - | - | 335.98 Thousand | 310.53 Thousand |
| Other Non Current Assets | - | - | - | - | - | - |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 180.7 Thousand | 138.49 Thousand | 398.73 Thousand | 17.28 Million | 3.32 Million | 3.08 Million |
| Total Current Liabilities | 180.7 Thousand | 138.49 Thousand | 398.73 Thousand | 17.28 Million | 1.43 Million | 1.21 Million |
| Account Payables | - | - | 77.07 Thousand | 9.33 Million | - | - |
| Tax Payables | 44.87 Thousand | 40.71 Thousand | 45.07 Thousand | 44.4 Thousand | 61.64 Thousand | 92.34 Thousand |
| Short Term Debt | - | - | - | 300 Thousand | 931.66 Thousand | 735.13 Thousand |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 180.7 Thousand | 138.49 Thousand | 321.65 Thousand | 7.64 Million | 499.66 Thousand | 480.44 Thousand |
| Total Non Current Liabilities | - | - | - | - | 1.89 Million | 1.86 Million |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | 1.55 Million | 1.55 Million |
| Other Liabilities | - | - | - | - | 1.00 | - |
| Total Equity | 4.27 Million | 8.49 Million | 9.04 Million | 10.06 Million | 6.93 Million | 7 Million |
| Stock Holders Equity | 4.27 Million | 8.49 Million | 9.04 Million | 10.06 Million | 6.93 Million | 7 Million |
| Common Stock | 3661.00 | 3661.00 | 3520.00 | 3520.00 | 9.75 Million | 9.53 Million |
| Retained Earnings | -19.5 Million | -15.54 Million | -15.07 Million | -14.05 Million | -2.82 Million | -2.52 Million |
| Accumulated other comprehensive income | -4.45 Million | - | - | - | - | - |
| Common Stock Equity | 4.27 Million | 8.49 Million | 9.04 Million | 10.06 Million | 6.93 Million | 7 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | 9.79 Million | 9.69 Million |
| Total Debt | - | - | - | 300 Thousand | 931.66 Thousand | 735.13 Thousand |
| Net Debt | -4.16 Million | -4.72 Million | -9.04 Million | -21.83 Million | 896.97 Thousand | 705.74 Thousand |
QSI
ENBI
NCRE
2357
688398
UTTAMSUGAR